In vivo imaging of glutamine metabolism to the oncometabolite 2-hydroxyglutarate in IDH1/2 mutant tumors Journal Article
| Authors: | Salamanca-Cardona, L.; Shah, H.; Poot, A. J.; Correa, F. M.; Di Gialleonardo, V.; Lui, H.; Miloushev, V. Z.; Granlund, K. L.; Tee, S. S.; Cross, J. R.; Thompson, C. B.; Keshari, K. R. |
| Article Title: | In vivo imaging of glutamine metabolism to the oncometabolite 2-hydroxyglutarate in IDH1/2 mutant tumors |
| Abstract: | The oncometabolite 2-hydroxyglutarate (2-HG) is a signature biomarker in various cancers, where it accumulates as a result of mutations in isocitrate dehydrogenase (IDH). The metabolic source of 2-HG, in a wide variety of cancers, dictates both its generation and also potential therapeutic strategies, but this remains difficult to access in vivo. Here, utilizing patient-derived chondrosarcoma cells harboring endogenous mutations in IDH1 and IDH2, we report that 2-HG can be rapidly generated from glutamine in vitro. Then, using hyperpolarized magnetic resonance imaging (HP-MRI), we demonstrate that in vivo HP [1-13C] glutamine can be used to non-invasively measure glutamine-derived HP 2-HG production. This can be readily modulated utilizing a selective IDH1 inhibitor, opening the door to targeting glutamine-derived 2-HG therapeutically. Rapid rates of HP 2-HG generation in vivo further demonstrate that, in a context-dependent manner, glutamine can be a primary carbon source for 2-HG production in mutant IDH tumors. Salamanca-Cardona et al. show that glutamine is a primary carbon source for the biosynthesis of the oncometabolite 2-hydroxyglutarate in mutant IDH tumors. They develop a novel hyperpolarized MRI method using glutamine as a probe to detect 2-hydroxyglutarate formation in vivo in real time, non-invasively, and with high specificity. © 2017 Elsevier Inc. |
| Keywords: | controlled study; treatment response; gene mutation; human cell; nonhuman; neuroimaging; nuclear magnetic resonance imaging; positron emission tomography; mouse; animal experiment; animal model; ph; in vivo study; in vitro study; biosynthesis; glioma cell; glutamine; polarization; cell mutant; proton nuclear magnetic resonance; carbon nuclear magnetic resonance; tumor microenvironment; citric acid cycle; 2 hydroxyglutaric acid; isocitrate dehydrogenase 1; liquid chromatography-mass spectrometry; amino acid metabolism; magnetic field; carbon source; 2-hydroxyglutarate; isocitrate dehydrogenase 2; hyperpolarization; pyroglutamic acid; human; female; priority journal; article; metabolic rate; hyperpolarized imaging; mutant isocitrate dehydrogenase; jj012 cell line |
| Journal Title: | Cell Metabolism |
| Volume: | 26 |
| Issue: | 6 |
| ISSN: | 1550-4131 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-12-05 |
| Start Page: | 830 |
| End Page: | 841.e3 |
| Language: | English |
| DOI: | 10.1016/j.cmet.2017.10.001 |
| PROVIDER: | scopus |
| PMCID: | PMC5718944 |
| PUBMED: | 29056515 |
| DOI/URL: | |
| Notes: | Article -- Export Date: 2 January 2018 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
Related MSK Work